Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

IC PaIN Trial: Interstitial Cystitis Pain Improvement With Naltrexone, the Effect of Low Dose Naltrexone on Symptoms and Pain of Patients With Interstitial Cystitis/Painful Bladder Syndrome a Randomized Placebo-controlled Prospective Trial

NCT04313972 is registered in ClinicalTrials.gov with Endeavor Health as lead sponsor.

NCT NCT04313972
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04313972 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
IC PaIN Trial: Interstitial Cystitis Pain Improvement With Naltrexone, the Effect of Low Dose Naltrexone on Symptoms and Pain of Patients With Interstitial Cystitis/Painful Bladder Syndrome a Randomized Placebo-controlled Prospective Trial
Lead sponsor
Endeavor Health
Phase
Phase 4
Overall status
Terminated
Start date
September 7, 2021
Completion date
February 23, 2023
Enrollment
3 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bladder pain syndrome, interstitial cystitis, low dose naltrexone, low-dose naltrexone, naltrexone, painful bladder syndrome